In this photo taken on January 18, 2024, Dr. Irene Flores, Clinical Head for the BPaL regimen for the drug resistant tuberculosis, shows the medicines for the BPaL regimen at a hospital in San Fernando, Pampanga. A faster and vastly more effective treatment for drug-resistant tuberculosis is being rolled out in the Asia-Pacific region, raising hopes of a "new era" in tackling one of the world's deadliest infectious diseases. (Photo by JAM STA ROSA / AFP)

New Treatment Offers Hope in Combatting Drug-Resistant TB in the Asia-Pacific Region

Learn more about the new treatment for drug-resistant TB in the Asia-Pacific region, offering hope for patients suffering from this deadly infectious disease. Trials have shown a cure rate of over 90% after just six months, providing a potential breakthrough in TB treatment. Read more about the impact of this new drug regimen and the experiences of patients like Efifanio Brillante.

Read More